The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Defining Medical Futility and Improving Medical Care
Open accessAbstract
It probably should not be surprising, in this time of soaring medical costs and proliferating technology, that an intense debate has arisen over the concept of medical futility. Should doctors be doing all the things they are doing? In particular, should they be attempting treatments that have little likelihood of achieving the goals of medicine? What are the goals of medicine? Can we agree when medical treatment fails to achieve such goals? What should the physician do and not do under such circumstances? Exploring these issues has forced us to revisit the doctor-patient relationship and the relationship of the medical profession to society in a most fundamental way. Medical futility has both a quantitative and qualitative component. I maintain that medical futility is the unacceptable likelihood of achieving an effect that the patient has the capacity to appreciate as a benefit. Both emphasized terms are important. A patient is neither a collection of organs nor merely an individual with desires. Rather, a patient (from the word "to suffer") is a person who seeks the healing (meaning "to make whole") powers of the physician. The relationship between the two is central to the healing process and the goals of medicine. Medicine today has the capacity to achieve a multitude of effects, raising and lowering blood pressure, speeding, slowing, and even removing and replacing the heart, to name but a minuscule few. But none of these effects is a benefit unless the patient has at the very least the capacity to appreciate it. Sadly, in the futility debate wherein some critics have failed or refused to define medical futility an important area of medicine has in large part been neglected, not only in treatment decisions at the bedside, but in public discussions-comfort care-the physician's obligation to alleviate suffering, enhance well being and support the dignity of the patient in the last few days of life.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888 · cited 1×
“…strict control failed to reduce adverse cardiovascular outcomes and either increased or had no effect on mortality; moreover, it increased the risk for severe hypoglycemia in type 2 diabetes (Gerstein et al. 2008; Duckworth et al. 2009; Patel et al. 2008; Kelly et al. 2009; Wiener et al. 2008).”
BackgroundIntensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
Glucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762 · cited 2×
“Well designed randomized control trials examining patient outcomes showed that strict control failed to reduce adverse cardiovascular outcomes and either increased or had no effect on mortality; moreover, it increased the risk for severe hypoglycemia in type 2 diabetes (Gerstein et al. 2008; Duckworth et al. 2009; Pat…”
BackgroundCorrection of anemia with epoetin alfa in chronic kidney disease
Singh, A. K., Szczech, L., Tang, K. L., Barnhart, H., Sapp, S., Wolfson, M., & Reddan, D. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa065485 · Cited by 2,762
Medical Futility: Its Meaning and Ethical Implications
Schneiderman, L. J., Jecker, N. S., & Jonsen, A. R. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-12-949 · Cited by 1,215 · cited 2×
“And so to overcome the paralysis of uncertainty that has forced physicians to pursue the most unlikely treatments, Nancy Jecker, Albert Jonsen, and I proposed what is nothing more than a commonsense definition of futility (Schneiderman et al. 1990).”
BackgroundSelf-citationSystematic review: glucose control and cardiovascular disease in type 2 diabetes
Kelly, T. N., Bazzano, L. A., Fonseca, V. A., Thethi, T. K., Reynolds, K., & He, J. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-6-200909150-00137 · Cited by 358 · cited 2×
“Well designed randomized control trials examining patient outcomes showed that strict control failed to reduce adverse cardiovascular outcomes and either increased or had no effect on mortality; moreover, it increased the risk for severe hypoglycemia in type 2 diabetes (Gerstein et al. 2008; Duckworth et al. 2009; Pat…”
BackgroundBenefits and Risks of Tight Glucose Control in Critically Ill Adults: A Meta-analysis
Wiener, R. S., Wiener, D. C., & Larson, R. J. (2008) · JAMA · doi:10.1001/jama.300.8.933 · Cited by 200
Cited by
Panchal, A. R., Bartos, J. A., Cabañas, J. G., Donnino, M. W., Drennan, I. R., Hirsch, K. G., Kudenchuk, P. J., Kurz, M. C., Lavonas, E. J., Morley, P. T., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000916 · Cited by 2,105
Topjian, A. A., Raymond, T. T., Atkins, D., Chan, M., Duff, J. P., Joyner, B. L., Lasa, J. J., Lavonas, E. J., Levy, A., Mahgoub, M., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000901 · Cited by 1,258
Allen, L. A., Stevenson, L. W., Grady, K. L., Goldstein, N. E., Matlock, D. D., Arnold, R. M., Cook, N. R., Felker, G. M., Francis, G. S., Hauptman, P. J., et al. (2012) · Circulation · doi:10.1161/cir.0b013e31824f2173 · Cited by 822
Shared decision-making in acute surgical illness: the surgeon’s perspective.
Morris, R. S., Ruck, J. M., Conca-Cheng, A. M., Smith, T. J., Carver, T. W., & Johnston, F. M. (2018) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2018.01.008 · Cited by 56
Metadata
- Authors
- Schneiderman, L. J.
- Venue
- Journal of Bioethical Inquiry
- Published
- 2011-03-20
- Volume
- 8
- Issue
- 2
- Pages
- 123-131
- ISSN
- 1176-7529 (ISSN-L)
- 1872-4353
- OpenAlex
- W2048146098
- Cited by
- 186
- References
- 7
- FWCI
- 7.94
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Defining Medical Futility and Improving Medical Care. https://app.cochat.ai/papers/10.1007/s11673-011-9293-3
- The paper
- Schneiderman, L. J. (2011). Defining Medical Futility and Improving Medical Care. Journal of Bioethical Inquiry. https://doi.org/10.1007/s11673-011-9293-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.